Outcome of Board Meeting held for consideration and approval of the unaudited Financial Results for the half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts less than Nifty Microcap 250 and 3.3 pts less than its Refineries & Marketing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Resgen Ltd's Board approved its unaudited H1 FY26 results on 14th November 2025. Revenue from operations rose 47.4% year-on-year to Rs. 3,787.43 lakhs (vs Rs. 2,568.59 lakhs in H1 FY25). However, total expenses grew faster at 59.4% to Rs. 3,268.73 lakhs, driven mainly by higher raw material costs and other expenses. Profit after tax inched up just 5.2% to Rs. 403.45 lakhs (vs Rs. 383.53 lakhs), while EPS stood at Rs. 1.92 (vs Rs. 1.83). The company's operating cash flow was healthy at Rs. 789.75 lakhs. Auditor Jay Gupta & Associates issued an unqualified limited review report with no qualifications or emphasis of matter.
Strong top-line growth is encouraging, but the sharp jump in costs has compressed margins meaningfully, meaning shareholders are not seeing proportional profit growth. Watch how the company manages cost efficiency in upcoming quarters; the margin pressure is the main concern despite healthy revenue expansion.